Cargando…
Astragaloside IV Alleviates Intestinal Barrier Dysfunction via the AKT-GSK3β-β-Catenin Pathway in Peritoneal Dialysis
Background and aims: Long-term peritoneal dialysis (PD) causes intestinal dysfunction, including constipation, diarrhea, or enteric peritonitis. However, the etiology and pathogenesis of these complications are still unclear and there are no specific drugs available in the clinic. This study aims to...
Autores principales: | He, Jiaqi, Wang, Mengling, Yang, Licai, Xin, Hong, Bian, Fan, Jiang, Gengru, Zhang, Xuemei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091173/ https://www.ncbi.nlm.nih.gov/pubmed/35571132 http://dx.doi.org/10.3389/fphar.2022.873150 |
Ejemplares similares
-
Astragaloside IV Inhibits the Progression of Non-Small Cell Lung Cancer Through the Akt/GSK-3β/β-Catenin Pathway
por: Jia, Liwei, et al.
Publicado: (2019) -
Astragaloside IV Enhances Melanogenesis via the AhR-Dependent AKT/GSK-3β/β-Catenin Pathway in Normal Human Epidermal Melanocytes
por: Liu, Baoyi, et al.
Publicado: (2020) -
Astragaloside-IV modulates NGF-induced osteoblast differentiation via the GSK3β/β-catenin signalling pathway
por: Sun, Nan-Yang, et al.
Publicado: (2021) -
Astragalus polysaccharides and astragaloside IV alleviate inflammation in bovine mammary epithelial cells by regulating Wnt/β-catenin signaling pathway
por: Fan, Jiaqi, et al.
Publicado: (2022) -
Astragaloside IV (AS-IV) alleviates the malignant biological behavior of hepatocellular carcinoma via Wnt/β-catenin signaling pathway
por: Jiang, ZhongYu, et al.
Publicado: (2019)